PAVmed to Hold a Business Update Conference Call and Webcast on August 14, 2025
PAVmed (Nasdaq: PAVM), a diversified commercial-stage medical technology company, has scheduled a business update conference call and webcast for August 14, 2025, at 8:30 AM ET. During the call, Chairman and CEO Dr. Lishan Aklog will discuss company operations and growth strategy, while President and CFO Dennis McGrath will present Q2 2025 financial results.
Investors can access the webcast through PAVmed's investor relations website. For telephone access, U.S. callers should dial 1-800-836-8184, while international callers can use 1-646-357-8785. A 30-day replay will be available on the company website following the call.
PAVmed (Nasdaq: PAVM), un'azienda tecnologica medica diversificata in fase commerciale, ha programmato una conference call e webcast per l'aggiornamento aziendale il 14 agosto 2025 alle 8:30 AM ET. Durante la chiamata, il Presidente e CEO Dr. Lishan Aklog parlerà delle operazioni aziendali e della strategia di crescita, mentre il Presidente e CFO Dennis McGrath presenterà i risultati finanziari del secondo trimestre 2025.
Gli investitori possono accedere al webcast tramite il sito web delle relazioni con gli investitori di PAVmed. Per l'accesso telefonico, i chiamanti dagli Stati Uniti dovrebbero comporre il numero 1-800-836-8184, mentre i chiamanti internazionali possono utilizzare il numero 1-646-357-8785. Una replica della chiamata sarà disponibile sul sito aziendale per 30 giorni dopo la conferenza.
PAVmed (Nasdaq: PAVM), una empresa tecnológica médica diversificada en etapa comercial, ha programado una conferencia telefónica y webcast para una actualización comercial el 14 de agosto de 2025 a las 8:30 AM ET. Durante la llamada, el Presidente y CEO Dr. Lishan Aklog hablará sobre las operaciones de la empresa y la estrategia de crecimiento, mientras que el Presidente y CFO Dennis McGrath presentará los resultados financieros del segundo trimestre de 2025.
Los inversores pueden acceder al webcast a través del sitio web de relaciones con inversores de PAVmed. Para el acceso telefónico, los llamantes de EE. UU. deben marcar 1-800-836-8184, mientras que los llamantes internacionales pueden usar 1-646-357-8785. Una repetición estará disponible en el sitio web de la empresa durante 30 días después de la llamada.
PAVmed (나스닥: PAVM)은 상업 단계의 다양한 의료 기술 회사로, 2025년 8월 14일 오전 8시 30분(동부시간)에 사업 업데이트 컨퍼런스 콜 및 웹캐스트를 예정하고 있습니다. 콜 동안 회장 겸 CEO인 Dr. Lishan Aklog가 회사 운영 및 성장 전략에 대해 논의하며, 사장 겸 CFO인 Dennis McGrath가 2025년 2분기 재무 결과를 발표할 예정입니다.
투자자들은 PAVmed의 투자자 관계 웹사이트를 통해 웹캐스트에 접속할 수 있습니다. 전화 접속의 경우 미국 내에서는 1-800-836-8184번으로, 국제 전화는 1-646-357-8785번으로 전화하면 됩니다. 콜 종료 후 30일간 회사 웹사이트에서 재청취가 가능합니다.
PAVmed (Nasdaq : PAVM), une entreprise technologique médicale diversifiée en phase commerciale, a programmé une conférence téléphonique et un webcast pour une mise à jour commerciale le 14 août 2025 à 8h30 ET. Lors de l'appel, le président-directeur général, Dr Lishan Aklog, discutera des opérations de l'entreprise et de la stratégie de croissance, tandis que le président et directeur financier, Dennis McGrath, présentera les résultats financiers du deuxième trimestre 2025.
Les investisseurs peuvent accéder au webcast via le site web des relations investisseurs de PAVmed. Pour un accès téléphonique, les appelants aux États-Unis doivent composer le 1-800-836-8184, tandis que les appelants internationaux peuvent utiliser le 1-646-357-8785. Une rediffusion sera disponible sur le site de l'entreprise pendant 30 jours après l'appel.
PAVmed (Nasdaq: PAVM), ein diversifiziertes Medizintechnikunternehmen in der kommerziellen Phase, hat für den 14. August 2025 um 8:30 Uhr ET eine Telefonkonferenz und Webcast zur Geschäftsaktualisierung geplant. Während des Anrufs wird Vorsitzender und CEO Dr. Lishan Aklog über die Unternehmensaktivitäten und Wachstumsstrategie sprechen, während Präsident und CFO Dennis McGrath die Finanzergebnisse für das zweite Quartal 2025 präsentieren wird.
Investoren können über die Investor-Relations-Website von PAVmed auf den Webcast zugreifen. Für den telefonischen Zugang wählen Anrufer aus den USA bitte 1-800-836-8184, internationale Anrufer können 1-646-357-8785 verwenden. Eine 30-tägige Wiedergabe wird nach dem Anruf auf der Unternehmenswebsite verfügbar sein.
- None.
- None.
Conference Call and Webcast at 8:30 AM Eastern Time
The webcast will be available at the investor relations section of the Company's website at pavmed.com. Alternatively, to access the conference call by telephone,
Following the conclusion of the conference call, a replay will be available for 30 days on the investor relations section of the Company's website at pavmed.com.
About PAVmed
PAVmed Inc. is a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors. Its subsidiary, Lucid Diagnostics (Nasdaq: LUCD), is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard® Esophageal DNA Test and EsoCheck® Esophageal Cell Collection Device—the first and only commercial tools for widespread early detection of esophageal precancer to mitigate the risks of esophageal cancer deaths. Its other subsidiary, Veris Health Inc., is a digital health company focused on enhanced personalized cancer care through remote patient monitoring using implantable biologic sensors with wireless communication along with a custom suite of connected external devices. Veris is concurrently developing an implantable physiological monitor, designed to be implanted alongside a chemotherapy port, which will interface with the Veris Cancer Care Platform.
For more and for more information about PAVmed, please visit pavmed.com.
For more information about Lucid Diagnostics, please visit luciddx.com.
For more information about Veris Health, please visit verishealth.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/pavmed-to-hold-a-business-update-conference-call-and-webcast-on-august-14-2025-302517035.html
SOURCE PAVmed Inc.
FAQ
When is PAVmed's (PAVM) Q2 2025 earnings call scheduled?
How can investors access PAVmed's (PAVM) Q2 2025 earnings call?
Who will be presenting at PAVmed's (PAVM) Q2 2025 earnings call?
How long will the replay of PAVmed's (PAVM) Q2 2025 earnings call be available?
